CClinicalTrials.gg
Status unknownNCT03660358Updated Sep 10, 2018

Effect of Kinesiotaping Application in Preterm Infants Undergoing Noninvasive Ventilation

An interventional study of kinesiotape application in Preterm Infant, sponsored by Baskent University. Status unknown at 1 site in Turkey. Open to participants aged 24 Weeks to 36 Weeks. Per ClinicalTrials.gov, last updated 2018-09-10.

Sponsored by Baskent University · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Sep 2018), so the status shown — last known as Recruiting — may be out of date.

From the registry’s dates

  • Registered 4 months after the study started (first participant enrolled May 2018, registered Sep 2018).
Phase
Not applicable
Study type
Interventional
Enrollment
42
Allocation
Randomized
Ages
24 Weeks to 36 Weeks
Sex
All
01

Study summary

Kinesiotaping (KT) applied to the thorax is believed to enhance breathing by supporting the respiratory muscles. Infants born premature usually have respiratory problems because of depletion of surfactant and respiratory muscle weakness. Therefore, we are going to use KT for premature infants in NICU who are undergoing non-invasive ventilation. Forty-two participants divided into two groups. The first group will be applied KT to chest wall, abdomen and diaphragm, and the other group will not receive any KT application during non-invasive ventilation. KT application will be going on as long as the infant underwent non-invasive ventilation. We are going to measure blood gas parameters (pH, pCO2, pO2, base excess), respiration rate, peak heart rate, percentage of Fio2, FiO2/pO2 rate, PEEP and PIP values before non-invasive ventilation, 2 hours after non-invasive ventilation, within 72 hours and shortly before weaning from non-invasive ventilation.

02

Conditions studied

  • Preterm Infant

Browse trials for

Keywords

  • preterm infants
  • kinesiotape
  • ventilation
  • respiratory muscles
03

In context

Premature Birth

2,554 studies on the registry are indexed under Premature Birth; 498 are open to participants now.

This study's planned enrollment of 42 is below the median of 84 across 1,689 interventional studies indexed under Premature Birth.

Browse Premature Birth studies →

Lead sponsor

Baskent University is the lead sponsor of 201 studies on the registry; 36 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
24 Weeks to 36 Weeks
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Inpatient infants in NICU, born in Baskent University Ankara Hospital, undergoing non-invasive ventilation and age between 24-36.6 weeks.

Exclusion criteria

Exclusion Criteria:

  • Infants with multiple kongenital anomaly, hypoxic ischemic encephalopathy, tracheoesophageal fistula, diaphragmatic hernia.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Single group
Masking
None (open label)
Enrollment
42 participants (estimated)

Study arms

  • Experimental
    Kinesiotape

    Kinesiotaping aplication to chest wall, abdomen and diaphragm in preterm infants.

    Device: kinesiotape application

  • No intervention
    Control

    No kinesiotaping aplication to chest wall, abdomen and diaphragm in preterm infants.

Interventions

  • Devicekinesiotape application

    kinesiotape application to diaphragm, chest wall and abdomen in preterm infants.

06

What researchers measure

Primary outcomes

  1. arterial blood gas

    arterial blood gas

    Time frame: 1 day

07

Study locations

1 of 1 sites recruiting
  • Baskent University Ankara Hospital
    Ankara, Bahçelievler, Turkey
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 10, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03660358
Lead sponsor
Baskent University
Responsible party
Nilay Comuk Balci (Associate Professor, Baskent University) — Principal investigator
First posted
Sep 6, 2018
Start date
May 1, 2018
Primary completion
May 1, 2019 (estimated)
Completion
May 1, 2019 (estimated)
Last update
Sep 10, 2018

Study contacts

Nilay Comuk Balci, Pt, PhD
Contact
nlycmk@yahoo.com
+905067115879
Ayse Ecevit, MD
Contact
ayseecevit@yahoo.com
+905348937200
Ayse Ecevit, MD
study director · Associate Professor

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Sep 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion